Study: Nalls, 2014

Population Ethnicity Diagnosis Source # Cases (% women) # Controls (% women) AAO (sd) AAO range AAE (sd) AAE range Ctrl age (sd) Ctrl age range # Polymorphisms
23andMe.v2 (USA, Europe) C self-reported clinical diagnosis O 3261 (39%) 29499 (42%) 64 (11) - - - 49 (15) - 9,752

Polymorphisms in this population [-]

Polymorphism Location (hg19) Gene Allele contrast Ethnicity # Studies # Samples 1000G CEU 1000G CHB+JPT Meta OR (95%CI) I2 (95%CI) Meta P-value
rs62059799 chr17:7445509 TNFSF12 [-6699bp] C vs. T All: C 15 108,990 - - 0.90 (0.86-0.95) 0 (0-52) 6.84e-05
rs9892297 chr17:7446027 TNFSF12 [-6181bp] G vs. A All: C 15 108,990 0.35 (G) 0.375 (A) 1.07 (1.03-1.11) 0 (0-40) 8.83e-05
rs78002826 chr17:7447636 TNFSF12 [-4572bp] T vs. C All: C 15 108,990 0.133 (T) 0.167 (T) 1.11 (1.05-1.16) 0 (0-52) 7.04e-05
rs9899326 chr17:7447764 TNFSF12 [-4444bp] A vs. G All: C 15 108,990 0.133 (A) 0.15 (A) 1.11 (1.05-1.16) 0 (0-52) 7.04e-05
rs9907930 chr17:7447854 TNFSF12 [-4354bp] T vs. G All: C 15 108,990 - - 0.90 (0.86-0.95) 0 (0-52) 6.72e-05
rs62059800 chr17:7448573 TNFSF12 [-3635bp] G vs. A All: C 15 108,990 - - 0.90 (0.86-0.95) 0 (0-52) 6.35e-05
rs28723678 chr17:7448642 TNFSF12 [-3566bp] C vs. T All: C 15 108,990 - - 0.91 (0.86-0.95) 0 (0-52) 7.42e-05
rs77711855 chr17:7452542 TNFSF12 T vs. C All: C 15 108,990 0.133 (T) - 1.11 (1.05-1.16) 0 (0-51) 7.18e-05
rs6608 chr17:7464413 TNFSF12 T vs. C All: C 15 108,990 0.225 (T) 0.067 (T) 1.09 (1.04-1.13) 0 (0-53) 6.73e-05
rs11654859 chr17:7465339 SENP3 T vs. C All: C 15 108,990 0.225 (T) - 1.09 (1.05-1.14) 0 (0-53) 4.67e-05
rs4542712 chr17:7469327 SENP3 C vs. T All: C 15 108,990 0.233 (C) 0.208 (C) 1.09 (1.04-1.13) 0 (0-52) 7.49e-05
rs9901673 chr17:7484101 CD68 A vs. C All: C 15 108,990 0.233 (A) 0.217 (A) 1.09 (1.04-1.13) 0 (0-50) 9.16e-05
rs62059826 chr17:7485583 CD68 [+154bp] T vs. C All: C 15 108,990 0.233 (T) 0.225 (T) 1.09 (1.05-1.14) 2 (0-55) 4.63e-05
rs10852891 chr17:7490810 MPDU1 A vs. G All: C 15 108,990 0.233 (A) 0.225 (A) 1.08 (1.04-1.13) 0 (0-49) 1.11e-04
rs58614441 chr17:7508239 FXR2 T vs. C All: C 15 108,990 - - 0.92 (0.88-0.96) 30 (0-62) 7.86e-05
rs11655488 chr17:7508641 FXR2 G vs. A All: C 15 108,990 - - 0.93 (0.90-0.97) 22 (0-58) 1.54e-04
rs858519 chr17:7531965 SHBG C vs. T All: C 15 108,990 - - 0.94 (0.91-0.97) 0 (0-50) 8.93e-05
rs858518 chr17:7533025 SHBG G vs. A All: C 15 108,990 0.45 (G) 0.317 (G) 1.08 (1.05-1.12) 0 (0-52) 3.88e-06
rs727428 chr17:7537792 SHBG [+1092bp] T vs. C All: C 15 108,990 0.442 (T) 0.35 (C) 1.07 (1.03-1.10) 0 (0-51) 1.78e-04
rs7222810 chr17:8038099 PER1 [-5691bp] A vs. G All: C 15 108,990 0.375 (A) 0.083 (A) 0.94 (0.91-0.97) 0 (0-49) 2.13e-04
rs10462024 chr17:8051639 PER1 G vs. A All: C 15 108,990 0.392 (G) 0.142 (G) 0.94 (0.91-0.97) 0 (0-52) 9.93e-05
rs11868035 chr17:17715101 SREBF1 A vs. G All: C 21 120,238 0.258 (A) 0.142 (G) 0.94 (0.91-0.97) 40 (0-65) 2.43e-05
rs12450799 chr17:17730201 SREBF1 T vs. C All: C 15 108,990 0.292 (T) 0.042 (C) 0.94 (0.90-0.97) 19 (0-56) 6.09e-05
rs9902941 chr17:17733760 SREBF1 C vs. T All: C 15 108,990 0.292 (C) 0.042 (T) 0.94 (0.91-0.97) 30 (0-63) 1.64e-04
rs1889018 chr17:17734740 SREBF1 G vs. A All: C 15 108,990 0.292 (G) - 0.94 (0.91-0.97) 29 (0-62) 1.68e-04
rs4924821 chr17:17735952 SREBF1 T vs. C All: C 15 108,990 0.333 (T) 0.042 (C) 0.93 (0.90-0.97) 14 (0-52) 5.20e-05
rs4925117 chr17:17736252 SREBF1 C vs. A All: C 15 108,990 - - 1.07 (1.03-1.10) 27 (0-61) 9.67e-05
rs13306736 chr17:17740281 SREBF1 C vs. T All: C 15 108,990 0.342 (C) - 0.94 (0.91-0.97) 24 (0-59) 9.37e-05
rs8079321 chr17:17760789 TOM1L2 T vs. C All: C 15 108,990 0.292 (T) 0.125 (C) 0.94 (0.91-0.97) 26 (0-60) 1.62e-04
rs1889014 chr17:17767165 TOM1L2 C vs. T All: C 15 108,990 0.325 (C) 0.033 (T) 0.93 (0.90-0.96) 7 (0-44) 3.87e-05
rs9895335 chr17:17767767 TOM1L2 G vs. A All: C 15 108,990 - - 1.07 (1.04-1.11) 18 (0-55) 6.06e-05
rs8065497 chr17:17782649 TOM1L2 A vs. G All: C 15 108,990 0.358 (A) 0.033 (G) 0.94 (0.91-0.97) 0 (0-53) 5.78e-05
rs12943500 chr17:17790588 TOM1L2 C vs. T All: C 15 108,990 0.35 (C) 0.033 (T) 0.94 (0.91-0.97) 6 (0-56) 7.57e-05
rs8077338 chr17:17860546 TOM1L2 T vs. C All: C 15 108,990 - - 1.07 (1.03-1.10) 4 (0-55) 8.85e-05
rs6502629 chr17:17869642 TOM1L2 G vs. A All: C 15 108,990 0.35 (G) 0.033 (A) 0.94 (0.91-0.97) 4 (0-56) 8.98e-05
rs8079418 chr17:17924060 ATPAF2 T vs. C All: C 15 108,990 0.292 (T) - 0.94 (0.91-0.97) 0 (0-53) 2.69e-04
rs2955382 chr17:17947710 GID4 C vs. T All: C 15 108,990 0.333 (C) 0.033 (T) 0.93 (0.90-0.96) 8 (0-44) 3.96e-05
rs8066764 chr17:17974668 GID4 [+2950bp] T vs. C All: C 15 108,990 0.258 (T) 0.4 (C) 0.93 (0.90-0.96) 36 (0-66) 5.37e-05
rs2955360 chr17:17974887 GID4 [+3169bp] G vs. A All: C 15 108,990 0.333 (G) 0.042 (A) 0.93 (0.90-0.96) 23 (0-58) 5.55e-06
rs62073573 chr17:17976354 GID4 [+4636bp] A vs. G All: C 15 108,990 0.258 (A) - 0.93 (0.90-0.96) 32 (0-64) 5.80e-05
rs9303144 chr17:17977355 GID4 [+5637bp] C vs. T All: C 15 108,990 0.258 (C) 0.258 (T) 0.93 (0.90-0.96) 31 (0-63) 5.69e-05
rs4426402 chr17:17977926 GID4 [+6208bp] C vs. T All: C 15 108,990 0.258 (C) 0.258 (T) 0.93 (0.90-0.97) 32 (0-64) 7.00e-05
rs4561528 chr17:17979099 GID4 [+7381bp] T vs. C All: C 15 108,990 0.25 (T) - 0.93 (0.90-0.96) 28 (0-61) 5.05e-05
rs12943914 chr17:17980671 GID4 [+8953bp] G vs. A All: C 15 108,990 0.35 (G) 0.042 (A) 0.93 (0.90-0.96) 17 (0-54) 2.98e-06
rs59518074 chr17:17984162 DRG2 [-7038bp] A vs. G All: C 15 108,990 - - 1.08 (1.04-1.12) 23 (0-59) 5.97e-05
rs6502637 chr17:17986098 DRG2 [-5102bp] G vs. A All: C 15 108,990 0.258 (G) 0.375 (A) 0.93 (0.90-0.96) 31 (0-63) 4.13e-05
rs7212447 chr17:17987067 DRG2 [-4133bp] A vs. G All: C 15 108,990 0.258 (A) 0.375 (G) 0.93 (0.90-0.96) 31 (0-63) 4.18e-05
rs72827413 chr17:17988299 DRG2 [-2901bp] C vs. T All: C 15 108,990 0.342 (C) 0.042 (T) 0.93 (0.90-0.96) 16 (0-54) 3.28e-06
rs12952818 chr17:17988591 DRG2 [-2609bp] A vs. G All: C 15 108,990 - - 1.08 (1.05-1.12) 12 (0-50) 2.54e-06
rs4365346 chr17:17989373 DRG2 [-1827bp] T vs. G All: C 15 108,990 0.258 (T) 0.375 (G) 0.93 (0.90-0.96) 30 (0-62) 4.52e-05